Sanara Medtech (NASDAQ: SMTI) — Perfil da empresa, notícias e dados financeiros
Sanara Medtech develops wound and skin care products to improve patient outcomes for healthcare professionals and institutions.
Sanara Medtech
Sanara Medtech (NASDAQ:SMTI), (OTCQB:SMTI) specializes in developing, marketing, and distributing wound and skin care products to physicians, hospitals, and clinics. Its portfolio includes innovative solutions aimed at improving patient outcomes and reducing healthcare costs in the areas of wound and skin care. The company is focused on bringing to market products that meet the highest standards for efficacy, safety, and patient care. Sanara Medtech's projects range from advanced wound care treatments to surgical wound management, all designed with the objective of addressing the complex needs of wound healing and skin integrity. The company aims to enhance patient healing and provide healthcare professionals with superior solutions for wound and skin care management.
Resumo
Operações
Produtos e/ou serviços de Sanara Medtech
- Wound and skincare products designed to promote healing and manage infections in both surgical and chronic wounds.
- Surgical and wound care education programs for healthcare professionals to improve patient outcomes and care standards.
- Post-surgical recovery kits tailored to reduce the risk of infection and promote faster healing times for patients.
- Advanced telehealth services providing remote wound assessment and treatment recommendations, improving access to specialized wound care.
equipe executiva do Sanara Medtech
- Ronald T. NixonExecutive Chairman
- Seth D. YonPresident, CEO & Director
- Elizabeth B. TaylorChief Financial Officer
- Jacob A. WaldropChief Operating Officer
- Ashley M. MackeyPrincipal Accounting Officer
- Bill FitzgeraldChief Compliance Officer
- Nicholas Gachassin IIIGeneral Counsel
- Tricia MattesonVice President of Marketing
- Tyler PalmerChief Corporate Development & Strategy Officer
- Nina BiondaChief R&D Officer
Principais indicadores financeiros
Resultados divulgados pela Sanara Medtech, em USD.
- Cap. de mercado
- 301,7 mi
- Receita (TTM)
- 109,8 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.0
- Dividend yield
- —
- Margem de lucro
- -29.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 103,1 mi | 9,1 mi | -37,6 mi | |
| 86,7 mi | -6,7 mi | -9,7 mi | |
| 65 mi | -4,2 mi | -4,3 mi | |
| 45,8 mi | -12,5 mi | -7,9 mi |